Australia TGA ARTG recordDermatological extracorporeal shock wave therapy system
Australia TGA ARTG Registered Device · Elogio Asia Aust Pty Ltd · Medispec Ltd · Class IIb · Started February 07, 2018
Good Name: Elogio Asia Aust Pty Ltd - Dermatological extracorporeal shock wave therapy system
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- February 07, 2018
- Effective Date
- February 07, 2018
- Name
- Medispec Ltd
- Country
- Israel
- Address
- 40 Hataasiya St PO Box 292, Yehud, 5610103
Radial wave therapy is indicated for applying radial wave energy to the muscle, connective and bone tissues for pain relief, tissue regeneration and for treating of Cellulite over the body surface, typically for the regions of the thighs, buttocks, arms and lower abdominal wall.
Access comprehensive regulatory information for Dermatological extracorporeal shock wave therapy system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Elogio Asia Aust Pty Ltd, manufactured by Medispec Ltd in Israel. The device registration started on February 07, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.